The Board of Directors of Arkema met on November 7th 2012 to review the Company's condensed consolidated accounts for 3rd quarter 2012. At the end of the meeting, Thierry Le Hénaff, Chairman and CEO of Arkema, stated: "The Group achieved a steady high performance in a less favorable economic environment than last year. The 3rd quarter results, with an EBITDA margin close to 17% in the high end of the industry, clearly illustrate the internal progress made by the Group which is benefiting from the repositioning of its activities portfolio on more resilient niches with higher added value. Trends in end-markets and regions remained mixed, and in this context, Arkema pursues its targeted investment policy on its growth priorities and continues to strictly manage its activities."

Outlook

The 4th quarter will reflect the traditional year-end seasonality. Meanwhile, the soft demand observed in certain market segments, the challenging situation of the European economy, and the volatility of raw materials are likely to continue during the 4th quarter and to result in the cautious management by customers of their inventories at year-end.

In this environment, Arkema will continue to give priority to its internal dynamics in order to strengthen its positioning in specialty niches and in higher growth countries. The Group will strictly manage its activities, focusing in particular on controlling its fixed costs, its working capital and its capex. Arkema remains confident in its ability to deliver a very solid year, and confirms its target to achieve an EBITDA close to €1 billion in 2012.

The contribution of the Vinyl activities, divested beginning of July 2012, has been presented in accordance with IFRS 5 rules and terms. Income statement items and balance sheet items (only for 2011 for the balance sheet) for this business have been presented on a separate line in the income statement and the balance sheet. However, the cash flow statement includes flows related to the Vinyl business concerned.

Q3 2012 performance

Sales in 3rd quarter 2012 reached €1,606 million against €1,587 million in 3rd quarter 2011. The +2.8% net contribution of acquisitions and divestments (acquisition of Hipro Polymers and Casda Biomaterials and of Seppic's alcoxylates) offset the 2.4% decrease in volume resulting from a slowdown in some end-markets in September (automotive and construction in Europe, photovoltaics). The 4.5% sales price decrease primarily concerns, as expected, acrylic acid and fluorogases. The currency translation effect was positive at +5.3%, reflecting the strengthening of the US dollar versus the euro.

In a less favorable and more volatile economic environment, EBITDA stood at €266 million, at the same level as in 3rd quarter 2011, demonstrating the strength of the Group's results. The performance of Industrial Chemicals remained very solid, at the same level as last year, while Performance Products again delivered an excellent result with record EBITDA for a 3rd quarter, at €107 million.

EBITDA margin remained stable at a very high level, at 16.6%.

Recurring operating income reached €189 million against €198 million in 3rd quarter 2011, after deduction of €77 million depreciation and amortization, up by €9 million as a result of the acquisitions and the currency translation effect relating to the strengthening of the US dollar versus the euro.

Recurring operating margin stood at 11.8%.

Net income, Group share, for the continuing operations reached €123 million. This includes a

€54 million tax charge representing 28.6% of recurring operating income. This rate reflects the geographic split of the results and in particular the substantial weight of the North America activities in the Group's results. Net income also includes the -€14 million financial result, stable compared to 3rd quarter 2011. Net income, Group share, for the discontinued operations stood at -€7 million, corresponding primarily to postclosing adjustments related to the divestment of the Vinyl business beginning of July. Consequently, net income, Group share, stood at €116 million, i.e. 7.2% of sales and 6% up over 3^rd quarter 2011.

Segment performance Q3 2012

Sales in the Performance Products segment rose to €548 million, 5.6% up over 3rd quarter 2011. At €107 million, EBITDA reached a new all-time high for a 3rd quarter, while EBITDA margin stood at 19.5%. This performance reflects in particular the contribution of the acquisitions in biosourced polyamides 10 and alkoxylates, and the optimization of the product mix towards higher added value niche markets (oil and gas, lightweight materials for transportation, etc.), which offset the slowdown in demand seen in September in some end-markets (especially automotive in Europe and photovoltaics).

Industrial Chemicals sales reached €1,053 million against €1,063 million in 3rd quarter 2011. Volumes overall were stable compared to last year despite a slowdown in some markets, in particular automotive in Europe, and weak volumes in decorative paints. As expected, prices decreased in acrylic monomers and fluorogases compared to the very high baseline of 3rd quarter 2011. The currency translation effect was positive due to the strengthening of the US dollar versus the euro. EBITDA and EBITDA margin remained stable at €176 million and 16.7% respectively (against €175 million and 16.5% in 3rd quarter 2011).

Industrial Specialties made a strong contribution to this performance with €98 million EBITDA and a very high EBITDA margin of 20%. All Business Units in this segment achieved very strong performances in particular thanks to the solid performance of the North American activities (PMMA for the automotive market, fluorogases for refrigeration, thiochemicals for animal feed, hydrogen peroxide, etc.) and despite the expected sharp decline in HFC-125 margins in China.

Coating Solutions also reported a good performance with €78 million EBITDA and 14% EBITDA margin. In line with the beginning of the year, acrylic monomer margins returned to mid-cycle conditions. In coating resins, demand was weak in decorative paints, mostly in Europe. Industrial coatings (Coatex, Sartomer) reported excellent results.

Cash flow and net debt at September 30^th 2012

Over 3rd quarter 2012, Arkema generated free cash flow of +€144 million. This cash flow includes €76 million recurring investments and a reduction in working capital related to the traditional seasonality of the activities. At September 30th 2012, the working capital to sales ratio (3rd quarter 2012 sales multiplied by 4) stood at 17.7%. This ratio (working capital to annual sales) should decrease towards the end of the year and could be close to 16% by end of December.

After taking into account the impact of acquisitions and divestments (payment to Hipro and Casda minority shareholders, and €35 million cash out of expenses recorded end of June in P&L as part of the divestment of the Vinyl activities), net cash flow stood at +€85 million.

Net debt stood at €1,002 million at September 30th 2012 against €1,093 million at June 30th 2012, i.e. 43% gearing, significantly down on end of June (49%) and in line with the Group's objective to return to gearing of around 40% by year end.

Highlights since July 1^st 2012

Beginning of July 2012, Arkema completed the divestment of its Vinyl Products segment to the Klesch Group, marking a major milestone in its transformation.

On July 24th 2012, Arkema announced the successful startup of a 50% production capacity increase for its Kynar PVDF fluorinated polymers on its Changshu site in China. The Group thereby consolidates its leading position in this high added value product line serving the coatings, chemical engineering, offshore oil extraction, water treatment, lithium-ion batteries and photovoltaics markets.

At an Investor Day held on September 18th 2012, Arkema confirmed its ambition for 2016 to become a world leader in specialty chemicals and advanced materials, and presented its road map for 2020. By implementing a targeted growth strategy, the Group aims to achieve sales of €8 billion and a 16% EBITDA margin by 2016, while maintaining gearing below 40%. By 2020, the Group aims for sales of €10 billion with an EBITDA margin close to 17%. Finally, Arkema announced its intention to increase its 2012 dividend significantly and subsequently aim for a payout ratio of 30% of adjusted net income.

Early October 2012, Arkema finalized the acquisition of an acrylic additives and emulsions production site in Brazil. Together with its existing activities, this acquisition should enable Coatex to achieve sales in Brazil of the order of $20 million.

Early October 2012, Arkema finalized the divestment of its tin stabilizer business which accounts for annual sales of the order of €180 million. This operation is fully in line with the Group's objective to divest some €400 million of sales between 2012 and 2016.

On October 5th 2012, Arkema successfully completed the issue of an additional €250 million tranche to its original bond due April 30th 2020, increasing its size to an aggregate amount of €480 million. This new tranche, which has an annual yield slightly below 3%, has enabled Arkema to further benefit from favorable market conditions.

On October 6th 2012, on schedule, Arkema and CJ Cheil Jedang officially launched the construction of their bio-methionine and thiochemicals complex in Malaysia, a project that represents overall investments of some $450 million with a portfolio of internationally recognized brands.